Key facts
- Feel Therapeutics’s last known valuation is $22.0M (Oct 2019).
- It has raised $33.6M across 1 recorded rounds; the latest was Early Stage VC ($7.9M) in Aug 2020.
- Notable investors include Plug and Play Tech Center, SOSV, Gaingels, Felicis, HAX — 23 tracked in total.
- Feel Therapeutics has filed 2 Form Ds with the SEC since 2023, most recently Apr 2025 ($7.9M sold to 34 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 23 names
- ·Watchlist + deal alerts for Feel Therapeutics
Funding rounds
1 roundsAbout Feel Therapeutics
Developer of a digital precision medicine company designed to bring objective data and passive monitoring for mental health. The company's tool offers proprietary medical-grade wearables, algorithms, and digital biomarkers with precision digital drugs and digital therapeutics intended to generate evidence, enabling the healthcare industry to improve mental well-being and develop long-lasting positive emotional habits in patients.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2015
- Employees
- 26
- Website
- feeltherapeutics.com/
- Ownership
- Privately Held (backing)
Feel Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Feel Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Feel Therapeutics in its N-PORT filings yet. We sweep new filings monthly.